Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HDAC9 |
| Upstream (Parents) |
|---|
| (<<) ARSJ → HDAC9 |
| (<<) CCND1 → HDAC9 |
| (<<) DUSP5 → HDAC9 |
| (<<) ELK3 → HDAC9 |
| (<<) GALR3 → HDAC9 |
| (<<) GDNF → HDAC9 |
| (<<) KCTD12 → HDAC9 |
| (<<) MAP3K4 → HDAC9 |
| (<<) MREG → HDAC9 |
| (<<) PRNP → HDAC9 |
| (<<) RARB → HDAC9 |
| (<<) RHOB → HDAC9 |
| (<<) RHOC → HDAC9 |
| (<<) SPRR1A → HDAC9 |
| (<<) SPRR1B → HDAC9 |
| (<<) TIMP2 → HDAC9 |
| Downstream (Children) |
|---|
| HDAC9 → GLRX (>>) |
| HDAC9 → IFITM3 (>>) |
| HDAC9 → PIK3R2 (>>) |
| HDAC9 → SMO (>>) |
| HDAC9 → UBE2E3 (>>) |
| HDAC9 → ZNF467 (>>) |
